%0 Journal Article
%T DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
%A Alexander Egle
%A Andreas Weinhaeusel
%A Angela Risch
%A Clemens Hufnagl
%A Cornelia Hauser-Kronberger
%A Gabriel Rinnerthaler
%A Hubert Hackl
%A Richard Greil
%A Simon Peter Gampenrieder
%A Suzana Ilic
%A Walter Pulverer
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.23544
%X Background: Biomarkers predicting response to bevacizumab in breast cancer are still missing. Since epigenetic modifications can contribute to an aberrant regulation of angiogenesis and treatment resistance, we investigated the influence of DNA methylation patterns on bevacizumab efficacy.
%K Metastatic breast cancer
%K bevacizumab
%K methylation
%K signature
%K predictive
%U http://www.thno.org/v08p2278.htm